BIOLEVERAGE
ActiveSummary
BIOLEVERAGE has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,000 and a net result of €154,056. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 38,911 sector peers (NACE 70, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
31-12
Financial
Highest result since 2020net €154,056 ▲13.7%
Operating result €202,150, net result €154,056, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Liquidity doublescurrent ratio 2.07
Current ratio from 0.97 to 2.07.
31-12
Financial
Equity above €100,000Eq €139,664 ▲3,291%
5 profitable years in a row build equity to €139,664.
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
31-12
Financial
Weakest financial yearnet €16,008 ▼49.6%
Net result drops to €16,008, the lowest in the series; recovery starts the following year.
12-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100,000Eq €100,111 ▲46.5%
3 profitable years in a row build equity to €100,111.
11-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
15-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.